The Bazelet Group is the largest medical cannabis company in Israel, serving monthly 9,000 patients, which are nearly one half of the licensed users.
Bazelet processes the cannabis grown by four out of the eight legal farms in Israel. Bazelet products include cannabis buds in sealed barcoded packages, flowers ground in a proprietary method resulting in a product of unique quality, special cannabis cigarettes, cannabis extracts, vaporizer tablets, sustained-release capsules, topicals and suppositories. Additionally, Bazelet’s operations include secure delivery to 7,500 homes every month, educating newly licensed users (15,000 over the last 3 years), guiding and providing strain-selection advice to thousands of clients and operating a sophisticated call center.
Bazelet is constructing a new GMP plant with the capacity to serve 100,000 patients. Bazelet is also developing new technologies in various fields, including new delivery methods, vaporizers and veterinary applications.
Bazelet’s experience and production knowledge, frequent feedback from thousands of clients and dedicated science are combined in order to lead the cannabis industry in product quality, precision, cost reduction and serving the needs of special populations, such as epileptic children and patients in nursing homes or geriatric hospitals.
Medical Cannabis and R&D.
Visited 169 times, 1 Visit today